Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.
暂无分享,去创建一个
C. Kainz | A. Haitel | H. Wiener | C. Mian | K Czerwenka | P. Kohlberger | G. Breitenecker | C Kainz | K. Czerwenka | C Mian | D Bancher | P Kohlberger | A Haitel | J Stani | G Breitenecker | H Wiener | J. Stani | D. Bancher
[1] W. Sauerbrei,et al. Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis , 1994, International journal of cancer.
[2] F. X. Bosch,et al. The role of HPV in the etiology of cervical cancer. , 1994, Mutation research.
[3] M. Fox,et al. Chromosome changes in 43 carcinomas of the cervix uteri. , 1990, Cancer genetics and cytogenetics.
[4] C. Griffin,et al. Cytogenetic and FISH analysis of endometrial carcinoma. , 1994, Cancer genetics and cytogenetics.
[5] H. Klinger,et al. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. , 1996, Cancer research.
[6] H. Höfler,et al. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin‐embedded tissue sections with centromere‐specific dna probes , 1994, The Journal of pathology.
[7] P. Troncoso,et al. Trisomy 7: A potential cytogenetic marker of human prostate cancer progression , 1994, Genes, chromosomes & cancer.
[8] M. Chan,et al. Genetic lesion in the carcinogenesis of cervical cancer. , 1992, Anticancer research.
[9] C. Mok,et al. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. , 1992, Anticancer research.
[10] P. Rabbitts,et al. PCR‐RFLP studies on chromosome 3p in formaldehyde‐fixed, paraffin‐embedded cervical cancer tissues , 1994, International journal of cancer.
[11] R. Chaganti,et al. Allelotype analysis of cervical carcinoma. , 1994, Cancer research.
[12] L. Meisner,et al. Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia , 1996, Diagnostic cytopathology.
[13] J. Arseneau,et al. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] C. Woodworth,et al. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. , 1993, Critical reviews in oncogenesis.
[15] M. Qumsiyeh,et al. Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors. , 1991, Cancer genetics and cytogenetics.
[16] B H Mayall,et al. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. , 1991, Cancer research.
[17] J W Gray,et al. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[18] C. Rygaard,et al. Management of low-grade CIN: follow-up or treatment? , 1995, European journal of obstetrics, gynecology, and reproductive biology.
[19] V. Abeler,et al. Human papilloma virus has no prognostic significance in cervical carcinoma. , 1996, European journal of cancer.
[20] Chi-An Chen,et al. The genotypes and prognostic significance of human papillomaviruses in cervical cancer , 1994, International journal of cancer.
[21] A. Lamhonwah,et al. Mutations participating in interallelic complementation in propionic acidemia. , 1994, American journal of human genetics.
[22] H. Klinger,et al. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas , 1992, The Lancet.
[23] Y. Taketani,et al. Type of human papillomavirus is related to clinical features of cervical carcinoma , 1996, Cancer.
[24] Diane Solomon,et al. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. , 1993, Acta cytologica.
[25] J. Hofbauer,et al. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer. , 1997, The Journal of urology.
[26] A. Vecchione,et al. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. , 1994, Gynecologic oncology.
[27] K. Syrjänen,et al. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). , 1996, European journal of obstetrics, gynecology, and reproductive biology.